Fundraising FoxLeaps by Bayer — 2021 Investments
8 investments dated 2021 · listed companies and verified rows first · show all
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsREDMILEAlumni VenturesDigitalis VenturesDreamers VCRising TideAccess Industries+3 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersBill & Melinda Gates FoundationNovalis LifeSciences+1 more
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsALS Investment FundJoyance PartnersPsyMed VenturesSocial StartsApollo Health Ventures
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCGermin8 VenturesKdT Ventures
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)in
Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsAhren Innovation CapitalVertical Venture Partners
Huma is a cloud platform that provides regulated AI infrastructure for healthcare and life sciences organizations, enabling them to build AI-driven applications, analytics, and clinical workflows across 70+ countries through a federated network model.
AI & Machine LearningDigital HealthHealthtechLondon, GB
Dan Vahdat(Founder and CEO)in
Co-investorsFuture Positive CapitalHitachi VenturesKickstart InnovationRaptor GroupRho Capital PartnersRho Ventures+5 more
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLifelinkLongwood FundMedical Excellence CapitalNovartis Venture Fund+5 more
MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.
HealthtechLogistics & Supply ChainSaaSNew York, US
Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)
BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in
Co-investors7wire VenturesCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.